OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Navigating the Management of Hepatocellular Carcinoma	354
Contributors	50
Forthcoming Issues	40
Forthcoming Issues	33
Forthcoming Issues	33
Copyright	31
Recurrent and De Novo Liver Disease After Liver Transplantation	29
Forthcoming Issues	29
The Role of Liver Transplantation in Hepatocellular Carcinoma	28
Contributors	28
Forthcoming Issues	25
Artificial Intelligence and Machine Learning Applications in Liver Disease	24
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease	22
Endoscopic Ultrasound-Guided Liver Biopsy	21
Overview of New Targets for Hepatitis B Virus	19
Contents	19
Through the Scope Hepatobiliary Interventions in Patients with Liver Diseases: Minimizing Risks and Improving Outcomes	18
Management of Biliary Complications in Liver Transplant Recipients	18
Preface	17
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment	17
What is the Path Forward to Treat Hepatitis Delta Virus?	16
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination	16
Pathogenesis of Alcohol-Associated Liver Disease	16
Preface	15
Nonalcoholic Fatty Liver Disease in Latin America and Australia	15

Consultations in Liver Disease	15
The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients	14
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	14
Primary Biliary Cholangitis	14
Primary Sclerosing Cholangitis	13
Portal Hypertension and its Complications	13
Alcohol-Associated Liver Disease	13
Contributors	13
Recent Advances in Primary Biliary Cholangitis Treatment	12
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease	12
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings	11
Biliary Atresia in Children	11
Targeting Hepatitis B Virus DNA Using Designer Gene Editors	11
Minimal Hepatic Encephalopathy	11
Pharmacologic Management of Hepatic Encephalopathy	11
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis	10
Copyright	10
Current and Next-Generation Therapeutics in Hepatology	9
Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases	9
Novel Therapies in Primary Biliary Cholangitis	8
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats	8
The Liver in Diabetes and Metabolic Syndrome	8
Navigating Hepatocellular Carcinoma	8
Improving Diagnostic Yield in Indeterminate Biliary Strictures	8
Chronic Hepatitis B	8
The Liver in Hematologic Malignancies	8
Hepatorenal Syndrome	8
Hepatocellular Carcinoma	8
Copyright	8
Contents	8
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape	8
Beyond the Liver	8
Prognostic Scoring Systems in Primary Biliary Cholangitis	8
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease	8
Hepatitis B and C in Children	8
Forthcoming Issues	8
Treatment of Primary Sclerosing Cholangitis Including Transplantation	8
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis	7
Contents	7
Amyloidosis and the Liver	7
Preventing Readmissions for Hepatic Encephalopathy	7
Hepatic Encephalopathy	7
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?	7
State of the Art	7
Primary Biliary Cholangitis	7
The Evolving Role of Therapeutic Endoscopy in Patients with Chronic Liver Diseases	7
Renal Insufficiency in Patients with Cirrhosis	7
Kidney Allocation Issues in Liver Transplantation Candidates with Chronic Kidney Disease and Severe Kidney Liver Injury	7
Overview of Progressive Familial Intrahepatic Cholestasis	7
Hepatic Encephalopathy in Acute-on-Chronic Liver Failure	6

Autoimmune Hepatitis	6
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease	6
Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis	6
Genetics of Primary Biliary Cholangitis	6
Systemic Complications of Primary Biliary Cholangitis	6
Chronic Hepatitis B Virus and Hepatitis D Virus	6
Alagille Syndrome	6
Contributors	6
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis	6